Felding-Habermann B: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
Line 15: | Line 15: | ||
}} | }} | ||
== O2k-Workshop in the O2k-Network Lab == | == O2k-Workshop in the O2k-Network Lab == | ||
::::* [[IOC89]] | ::::* [[IOC89|IOC89 La Jolla US]] |
Latest revision as of 17:12, 13 February 2018
Name | Felding-Habermann Brunhilde, PhD, Associate Prof. |
---|---|
Institution | The Scripps Research Institute, MEM 150 |
Address | 10550 North Torrey Pines Road, 92037 |
City | La Jolla |
State/Province | California (CA) |
Country | USA |
brunie@scripps.edu | |
Weblink | |
O2k-Network Lab | US CA La Jolla Felding-Habermann B |
Labels:
Field of research: Basic, Clinical
Publications
Published | Reference | |
---|---|---|
Santidrian 2013 J Clin Invest | 2013 | Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, Leboeuf SE, Gay LJ, Yagi T, Felding-Habermann B (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 123:1068-81. |